English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.
Tag: COVID -19
Pharmacists can improve access to life-saving vaccines
HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.
Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
The COVID-19 pandemic spotlighted how a rapid and effective response to infectious disease outbreaks is critical for saving lives and protecting communities. With a $17.5 million, five-year grant from the U.S. Centers for Disease Control and Prevention (CDC), University of Utah researchers, in collaboration with Washington State University, are leading efforts to provide data and tools that guide decisions to improve responses to emerging public health threats in the Mountain West.
Study finds SARS-CoV-2-associated sepsis was more common, deadly than previously thought
Using data from Mass General Brigham’s electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic
Katalin Karikó and Drew Weissman, Penn’s Historic mRNA Vaccine Research Team, Win 2023 Nobel Prize in Medicine
PHILADELPHIA – The University of Pennsylvania messenger RNA pioneers whose years of scientific partnership unlocked understanding of how to modify mRNA to make it an effective therapeutic—enabling a platform used to rapidly develop lifesaving vaccines amid the global COVID-19 pandemic—have been named winners of the 2023 Nobel Prize in Physiology or Medicine.
Common symptoms of COVID-19 and often-overlooked symptoms
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. COVID-19 has been around for three years now. What are some of the recent common symptoms we are seeing? (SOT@…
Rutgers Experts on School Climate and Conditions for Learning Available to Comment on Post-COVID Educational Challenges
Dr. Alicia Raia-Hawrylak, Co-Project Manager for the School Climate Transformation Project (SCTP), is available to comment on post-COVID concerns related to school climate, including student behavior and bullying, social and emotional learning, staff retention, and using data to guide the…
Distinct immune, hormone responses shed light on mysteries of long COVID
People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID.
Six Numbers Predict Life-Threatening COVID-19
Rutgers develops a prognosis tool to help hospitals improve care.
Avoiding a “Tripledemic” This Winter
A Rutgers infectious disease expert explains what you need to know about this year’s flu, COVID and new RSV shots
Study details immune cells vital to success of vaccines against coronavirus
A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.
When it comes to COVID and the flu, an expert is available to speak about infection prevention and safety control
https://case.edu/nursing/about/fpb-directories/faculty-directory/shanina-c-knighton
Global Policymakers Call for Effective Infodemic Management to be a Substantive Article in the Pandemic Accord
Members of the Intergovernmental Negotiating Body Bureau continue the discussion on infodemic management in light of circulation of misinformation through social media during public health emergencies.
Five New Health Systems Partner with American Thoracic Society on Vaccine Initiative
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.
The Latest in Science and Medical Advancement in Otolaryngology-Head and Neck Surgery to be Presented at AAO-HNSF Annual Meeting
The latest research and advances in otolaryngology-head and neck surgery will be presented in Nashville, Tennessee, during the AAO-HNSF 2023 Annual Meeting & OTO Experience, September 30 – October 4.
Global background rates study analyzes data from 197 million people for assessment of COVID-19 vaccine safety
The US CDC (Centers for Disease Control and Prevention) funded Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.
Cell therapy can reduce risk of death from COVID-19 by 60%, study shows
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
ACP issues updated Rapid, Living Practice Points on treating COVID-19 patients in outpatient settings
In an updated rapid, living practice points, the American College of Physicians (ACP) summarizes the latest evidence on the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting, specifically addressing the dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. The paper is published in Annals of Internal Medicine
Immunity to COVID-19 reduces contagiousness
One in three people exposed to SARS-CoV2 is infected, and as many as two in five with the Omicron variant. In the case of immunity — conferred by vaccination, infection or a combination of the two — this rate drops to one in ten.
The pandemic a tough time also for pharmacies
Customers showing up even when they were sick, not agreeing with the restrictions, and many new tasks for staff. These are factors that contributed to heavier workloads and tougher work environments in pharmacies during the pandemic, a study reveals.
Getting vaccines for flu, RSV, pneumonia and COVID.
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…
Milestone in the fight against pandemics: Researchers at TU Dresden create pioneering approaches for the detection of viral antigens
The outbreak of the COVID pandemic in 2020 has once again shown how important reliable and rapid detection methods are to initiate effective measures to combat a pandemic.
The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square
Wexford Science & Technology, LLC and the University of Pennsylvania today announced that the University has signed a lease for new laboratory space that will usher in a wave of novel vaccine, therapeutics and engineered diagnostics research to West Philadelphia.
Public health expert offers advice re: new COVID-19 variants and fall vaccines
A late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for 13 days for the treatment of mild-to-moderate COVID-19 symptoms.
Rutgers Experts Available to Comment on the F.D.A. Approval of New Covid Shots
Perry N. Halkitis, dean of the Rutgers School of Public Health, and Richard Marlink, director of Rutgers Global Health Institute, are available to speak about the Food and Drug Administration’s approval of a new round of Covid vaccinations to be…
Wearable technology shows promise in early detection of COVID-19 among FSU athletes
In a groundbreaking study conducted by Florida State University, wearable technology has emerged as a potential game-changer in the early detection of COVID-19 among NCAA Division I female student-athletes.
Clinical Labs’ Quick Response to COVID-19 Helped Reduce Hospitalizations and Save Lives
A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives. However, the challenges labs faced with insufficient supplies and staffing shortages have only intensified since 2020. The percentage of laboratory professionals reporting staffing issues rose steadily from 35.4% in May 2020 to 87.5% in January 2022—raising questions about whether labs would have the necessary resources to respond to a similar public health emergency today.
Scancell’s DNA-based vaccine shown to be effective at protecting against COVID-19
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine.
Only Severe COVID Cases Disrupted Oral Microbiomes
Bacteria in the mouth mostly survived infection — and that’s a good thing, says a Rutgers researcher.
Study Shows Technology Boosts Public Health Programs
SCALE-UP Counts was designed to promote COVID-19 testing in local schools. Huntsman Cancer Insitute’s Yelena Wu, PhD, hopes the insight gained from the program improves cancer screening and education initiatives.
Viral evolution expert available for comment on new BA.2.86 COVID variant
URBANA, Ill. — Last week’s classification of BA.2.86 as a COVID “variant under monitoring” by the World Health Organization raises many epidemiological and public health questions. Among the unknowns is how the virus evolved to acquire 36 to 38 mutations…
Poor report card for children’s wellbeing
While COVID-19 lockdowns are no longer mandated, the stress and anxiety of the pandemic still lingers, especially among young South Australians, say health experts at the University of South Australia.
Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…
Rather than providing protection, an Omicron infection may leave patients more susceptible to future COVID infections, researchers find after studying seniors in care
Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.
Dr. Marc Elieson discusses concerns about COVID-19 and kids going back to school
Marc Elieson, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. The CDC says COVID cases will continue to increase this summer and when school resumes this fall. What is behind…
International Study Shows that Taste, Independent of Smell, Can Also be Significantly Diminished in Patients with COVID-19
Smell loss became the cardinal symptom of COVID-19 early in the pandemic and has ignited research on how smell and taste function. An international study led by the Global Consortium for Chemosensory Research (GCCR) and the Monell Chemical Senses Center has untied taste from smell in people with COVID-19, demonstrating in a large and diverse group of more than 10,000 people that taste, independent of smell, is also greatly impacted by COVID.
Nurses’ intentions to quit increased during the pandemic despite their high resilience
Nurses’ intentions to leave nursing increased during the COVID-19 pandemic, a recent study from the University of Eastern Finland shows. Yet, nurses estimated their resilience to be high.
More Than 2 Million Additional Americans Faced Food Insufficiency Following Drawdown of Pandemic-Related SNAP Benefits, Penn Medicine Study Finds
The recent discontinuation of pandemic-related food assistance benefits, known as the Supplemental Food Assistance Program (SNAP) Emergency Allotments, led to a substantial increase in food insufficiency in the United States, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.
Study Reveals Patients Hospitalized with COVID-19 Faced Nearly Twice the Rates of Death After Discharge As Patients with Flu
Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.
Researchers Find COVID-19 Causes Mitochondrial Dysfunction in Heart and Other Organs
A multi-institutional consortium of researchers has found that the genes of the mitochondria, the energy producers of our cells, can be negatively impacted by the virus, leading to dysfunction in multiple organs beyond the lungs. These findings suggest new approaches for treating COVID-19.
EG.5 COVID Variant: Johns Hopkins Bloomberg School of Public Health expert available
Andrew Pekosz, professor and vice chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, is available for media interviews to discuss the EG.5 COVID variant, which the Centers for Disease Control…
Expert can comment on Covid resurgence
As COVID-19 cases are rising, Rutgers School of Public Health dean Perry N. Halkitis is available to comment on new variants, vaccines, testing, and steps to protect the health of people and populations. The following quotes from Halkitis can be used…
Early-Stage Cancer Diagnoses Decreased Sharply in the U.S. During First Year of COVID-19 Pandemic; Underserved Greatly Affected
A new study from researchers at the American Cancer Society found monthly adult cancer diagnoses decreased by half in April 2020 during the COVID-19 pandemic in the United States. The largest decrease was for stage I cancers, resulting in a higher proportion of late-stage diagnoses.
ACP Says the U.S. Needs Immediate Action to Prepare for Future Pandemics
The United States has significant gaps in its pandemic and public health emergency response system leaving it unprepared for future emergencies, says the American College of Physicians (ACP) in a new policy paper. In the paper, ACP makes recommendations about what needs to be done to ensure the U.S. is in a strong position to mitigate the consequences of future pandemics. The paper is published in Annals of Internal Medicine.
SLU Researcher Examines Ethical Questions Raised During COVID-19 Pandemic
Michael Rozier, S.J., Ph.D., professor and department chair for health management and policy at Saint Louis University, has authored a paper examining ethical questions raised during the COVID-19 pandemic and what can be done, to address similar ethical questions in the future.
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.
Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
People who contract COVID-19 but never develop symptoms – the so-called super dodgers – may have a genetic ace up their sleeve. They’re more than twice as likely as those who become symptomatic to carry a specific gene variation that helps them obliterate the virus, according to a new study led by UC San Francisco researchers.
Demand for Counseling Services Remained Steady During Pandemic Despite Telehealth Delivery, Study Shows
People seeking mental health services during the COVID-19 pandemic were not deterred by the widespread shift to telehealth services, according to research findings published in the Journal of Counseling & Development, a journal of the American Counseling Association.